Celltrion Inc (068270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Celltrion Inc (Celltrion) is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn’s disease, psoriatic arthritis and psoriasis. Its pipeline portfolio spans monoclonal antibody biosmilars for the treatment of rheumatoid arthritis; colorectal cancer; large Intestine Cancer and respiratory disease; and antibody biologics for and vaccines for infectious diseases such as hepatitis B, influenza, rabies, breast cancer, seasonal influenza antibody; and antibody drug conjugates. Celltrion develops drugs by utilizing its bioengineering and mammalian cell-culture technology. The company also carries out contract manufacturing of biosimilars. It has operational presence in Korea, Russia, the UK, and the US. Celltrion is headquartered in Incheon city, South Korea.
Celltrion Inc Key Recent Developments
Jan 20,2016: Celltrion and Medidata Team Up to Transform Global Clinical Trials for Biosimilars
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
NOTE: Out of security concerns GlobalData requires using corporate email address.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Celltrion Inc (Celltrion) is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn’s disease, psoriatic arthritis and psoriasis. Its pipeline portfolio spans monoclonal antibody biosmilars for the treatment of rheumatoid arthritis; colorectal cancer; large Intestine Cancer and respiratory disease; and antibody biologics for and vaccines for infectious diseases such as hepatitis B, influenza, rabies, breast cancer, seasonal influenza antibody; and antibody drug conjugates. Celltrion develops drugs by utilizing its bioengineering and mammalian cell-culture technology. The company also carries out contract manufacturing of biosimilars. It has operational presence in Korea, Russia, the UK, and the US. Celltrion is headquartered in Incheon city, South Korea.
Celltrion Inc Key Recent Developments
Jan 20,2016: Celltrion and Medidata Team Up to Transform Global Clinical Trials for Biosimilars
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
NOTE: Out of security concerns GlobalData requires using corporate email address.
SECTION 1 - ABOUT THE COMPANY
Celltrion Inc - Key Facts
Celltrion Inc - Key Employees
Celltrion Inc - Major Products and Services
Celltrion Inc - History
Celltrion Inc - Company Statement
Celltrion Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Celltrion Inc - Business Description
Celltrion Inc - SWOT Analysis
SWOT Analysis - Overview
Celltrion Inc - Strengths
Celltrion Inc - Weaknesses
Celltrion Inc - Opportunities
Celltrion Inc - Threats
Celltrion Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Celltrion Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jan 20, 2016: Celltrion and Medidata Team Up to Transform Global Clinical Trials for Biosimilars
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Celltrion Inc - Key Facts
Celltrion Inc - Key Employees
Celltrion Inc - Major Products and Services
Celltrion Inc - History
Celltrion Inc - Company Statement
Celltrion Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Celltrion Inc - Business Description
Celltrion Inc - SWOT Analysis
SWOT Analysis - Overview
Celltrion Inc - Strengths
Celltrion Inc - Weaknesses
Celltrion Inc - Opportunities
Celltrion Inc - Threats
Celltrion Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Celltrion Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jan 20, 2016: Celltrion and Medidata Team Up to Transform Global Clinical Trials for Biosimilars
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Celltrion Inc, Key Facts
Celltrion Inc, Key Employees
Celltrion Inc, Major Products and Services
Celltrion Inc, History
Celltrion Inc, Subsidiaries
Celltrion Inc, Key Competitors
Celltrion Inc, Ratios based on current share price
Celltrion Inc, Annual Ratios
Celltrion Inc, Annual Ratios (Cont.1)
Celltrion Inc, Annual Ratios (Cont.2)
Celltrion Inc, Interim Ratios
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Celltrion Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Celltrion Inc, Key Facts
Celltrion Inc, Key Employees
Celltrion Inc, Major Products and Services
Celltrion Inc, History
Celltrion Inc, Subsidiaries
Celltrion Inc, Key Competitors
Celltrion Inc, Ratios based on current share price
Celltrion Inc, Annual Ratios
Celltrion Inc, Annual Ratios (Cont.1)
Celltrion Inc, Annual Ratios (Cont.2)
Celltrion Inc, Interim Ratios
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Celltrion Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Celltrion Inc, Performance Chart (2012 - 2016)
Celltrion Inc, Ratio Charts
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Celltrion Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
COMPANIES MENTIONED
ViroMed Co Ltd
Peptron Inc
JW Pharmaceutical Corp
Genexine Inc
ChoongAng Vaccine Laboratory
Alvogen Korea Co Ltd
Advanced Protein Technologies Corp
Skip to top
Celltrion Inc, Performance Chart (2012 - 2016)
Celltrion Inc, Ratio Charts
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Celltrion Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
COMPANIES MENTIONED
ViroMed Co Ltd
Peptron Inc
JW Pharmaceutical Corp
Genexine Inc
ChoongAng Vaccine Laboratory
Alvogen Korea Co Ltd
Advanced Protein Technologies Corp
Advanced Energy Industries Inc (AEIS) - Financial and Strategic SWOT Analysis Review
US$ 125.00
Mar, 2018 · 43 pages
The Andersons Inc (ANDE) - Financial and Strategic SWOT Analysis Review
US$ 125.00
Jan, 2018 · 41 pages